Introduction to "Immunotherapies for Multiple Myeloma".

Published in: Pharmaceuticals (Basel, Switzerland) (2020)

Multiple myeloma (MM) is the second most common hematological cancer after diffuse large B-cell lymphoma, accounting for about 10% of all blood cancers [...].

Keyphrases

diffuse large b cell lymphoma
multiple myeloma
epstein barr virus
papillary thyroid
squamous cell
childhood cancer
lymph node metastasis
squamous cell carcinoma